Cidel Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $633K | Buy |
1,560
+191
| +14% | +$77.4K | 0.04% | 172 |
|
|
2025
Q1 | $681K | Buy |
1,369
+56
| +4% | +$27.9K | 0.04% | 154 |
|
|
2024
Q4 | $683K | Buy |
1,313
+38
| +3% | +$19.8K | 0.05% | 157 |
|
|
2024
Q3 | $789K | Buy |
1,275
+53
| +4% | +$32.8K | 0.06% | 140 |
|
|
2024
Q2 | $676K | Buy |
1,222
+38
| +3% | +$21K | 0.05% | 146 |
|
|
2024
Q1 | $688K | Sell |
1,184
-149
| -11% | -$86.6K | 0.05% | 151 |
|
|
2023
Q4 | $708K | Sell |
1,333
-39,577
| -97% | -$21M | 0.03% | 148 |
|
|
2023
Q3 | $20.7M | Sell |
40,910
-51
| -0.1% | -$25.8K | 1.04% | 32 |
|
|
2023
Q2 | $21.4M | Buy |
40,961
+2,540
| +7% | +$1.33M | 0.97% | 34 |
|
|
2023
Q1 | $22.1M | Buy |
38,421
+173
| +0.5% | +$99.7K | 1.02% | 34 |
|
|
2022
Q4 | $21.1M | Sell |
38,248
-379
| -1% | -$209K | 0.99% | 35 |
|
|
2022
Q3 | $19.6M | Buy |
+38,627
| New | +$19.6M | 0.93% | 37 |
|